Symbol="KALA"
AssetType="Common Stock"
Name="Kala Pharmaceuticals Inc"
Description="Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1479419"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="100 BEAVER STREET, SUITE 201, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="33609800"
EBITDA="-60114000"
PERatio="None"
PEGRatio="0"
BookValue="10.16"
DividendPerShare="0"
DividendYield="0"
EPS="-14.62"
RevenuePerShareTTM="1.512"
ProfitMargin="0"
OperatingMarginTTM="-24.04"
ReturnOnAssetsTTM="-0.412"
ReturnOnEquityTTM="-2.898"
RevenueTTM="2520000"
GrossProfitTTM="1332000"
DilutedEPSTTM="-14.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="32"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.157"
PriceToBookRatio="2.944"
EVToRevenue="0.0421"
EVToEBITDA="0.0299"
Beta="-1.532"
num_52WeekHigh="56.72"
num_52WeekLow="3.544"
num_50DayMovingAverage="15.46"
num_200DayMovingAverage="13.58"
SharesOutstanding="2348700"
DividendDate="None"
ExDividendDate="None"
symbol="KALA"
open="14.79"
high="14.79"
low="14.40"
price="14.57"
volume="26176.00"
latest_trading_day="2023-07-12"
previous_close="14.31"
change="0.26"
change_percent="1.8169%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="18"
trend_strength="Strong Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="82"
Volume_recent_avg="413894"
Change_recent_avg="0.04"
Delta_recent_avg="1.49"
Variance_recent_avg="0.74"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="82"
Aroon_momentum_negative="18"
image_negative_thumbnail_id_1="154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_negative_thumbnail_id_2="515"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="631"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0077.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
